Oak Family Advisors LLC lowered its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,431 shares of the company’s stock after selling 278 shares during the period. Oak Family Advisors LLC’s […]
GW&K Investment Management LLC cut its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 2.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 336,536 shares of the company’s stock after selling 9,204 shares during the quarter. GW&K Investment Management LLC’s holdings […]
BNP Paribas Asset Management Holding S.A. boosted its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 7.1% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 628,527 shares of the company’s stock after acquiring an additional 41,615 shares during the period. BNP Paribas Asset Management Holding S.A.’s holdings in AbbVie were […]
BNP Paribas Asset Management Holding S.A. lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 7.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 628,527 shares of the company’s stock after purchasing an additional 41,615 […]
Cantor Fitzgerald initiated coverage on shares of AbbVie (NYSE:ABBV – Free Report) in a research note released on Friday, MarketBeat.com reports. The brokerage issued an overweight rating and a $200.00 target price on the stock. ABBV has been the topic of several other reports. Guggenheim increased their price target on shares of AbbVie from $188.00 […]